<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR13">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Conroy</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Desseigne</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Ychou</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bouche</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Guimbaud</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Becouarn</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer</article-title>
  <source>N Engl J Med</source>
  <year>2011</year>
  <volume>364</volume>
  <issue>19</issue>
  <fpage>1817</fpage>
  <lpage>1825</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1011923</pub-id>
  <?supplied-pmid 21561347?>
  <pub-id pub-id-type="pmid">21561347</pub-id>
 </element-citation>
</ref>
